Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q2 2022 · 10-Q
Revenue$18.68M$18.68M+23.4% vs Q2 2021 Net Income-$4.97M-$4.97MN/M vs Q2 2021 EPS Diluted-$0.43-$0.43N/M vs Q2 2021 Gross Profit$1,745,000N/M Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,904,000N/M Margins · derivedGross margin9.3%+11.1 pt vs Q2 2021
Operating margin-24.0%+27.7 pt vs Q2 2021
Net margin-26.6%+28.9 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end